H-L-Met-AMC*TFA

H-L-Met-AMC*TFA is a methionine-based peptide substrate/derivative featuring an N-terminal His-Leu dipeptide motif linked to an AMC fluorophore (7-amino-4-methylcoumarin) through a peptide bond at the C-terminus, with methionine retained as the thioether side chain. The compound is supplied as a TFA salt, indicating protonation of the amine functionality and improved handling for aqueous or mixed-solvent assay workflows, while the AMC chromophore provides strong fluorescence upon enzymatic release. The stereochemistry is defined by the L-configuration of the amino acid residues, which governs recognition by proteases and peptide-processing enzymes. The presence of both peptide amide linkages and a thioether side chain creates a chemically realistic platform for studying proteolysis, optimizing substrate specificity, and generating downstream analytical standards or mechanistic probes.

1. Protease Substrate Assays

H-L-Met-AMC*TFA is applied in protease activity screening and mechanistic studies where peptide bond cleavage yields a fluorescent AMC readout. The His-Leu-Met sequence and the terminal AMC leaving group are compatible with enzyme recognition motifs, while the L-stereochemical configuration supports stereospecific substrate binding. The thioether side chain of methionine can influence local hydrophobicity and sulfur-containing interactions that affect substrate turnover and specificity. The TFA salt form supports reproducible solubilization for analytical research and enables generation of enzyme kinetics datasets used to compare substrate variants or inhibitor modes. The resulting AMC-containing cleavage products also serve as traceable intermediates for downstream analytical method development in biochemical research.

2. Enzyme Inhibitor Profiling

H-L-Met-AMC*TFA functions as a substrate component for inhibitor profiling in biochemical research, enabling discrimination between inhibitors that alter catalytic efficiency versus substrate binding. The intact peptide amide bonds and the AMC reporter position the compound for monitoring changes in fluorescence output as a function of enzyme processing. The defined L-amino acid stereochemistry and the specific sequence context (His-Leu-Met) support realistic structure-function relationships in protease active-site studies. The methionine thioether can participate in substrate-enzyme contact patterns, making the substrate useful for comparing inhibitor families that target hydrophobic pockets or sulfur-tolerant environments. The TFA salt form helps maintain consistent assay conditions for fine chemical synthesis workflows that generate inhibitor libraries and corresponding analytical reference materials.

3. Peptidomimetic SAR Tools

H-L-Met-AMC*TFA can be used as an experimental scaffold in structure-activity relationship (SAR) studies for peptidomimetic design, where the peptide backbone and AMC reporter enable rapid readout of sequence-dependent processing. The His-Leu dipeptide region and the methionine side chain provide defined interaction elements that can be systematically modified by substituting residues or altering side-chain electronics to map recognition determinants. The AMC tag supports semiquantitative monitoring of cleavage events, which can guide selection of analogs for further synthesis and characterization. The TFA salt form also supports reproducible handling during iterative medicinal chemistry and process chemistry intermediate preparation. The compound thus serves as a practical bridge between amino acid chemistry and peptide science, supporting rational design of substrate-like probes and peptidomimetic candidates.

4. Analytical Fluorogenic Standards

H-L-Met-AMC*TFA is utilized in analytical research as a fluorogenic reference material for method validation and calibration in enzyme-coupled assays and fluorescence-based quantitation. The AMC chromophore provides a measurable optical signal after cleavage, while the peptide-derived structure ensures that the signal arises from controlled enzymatic transformation rather than nonspecific fluorescence. The presence of multiple amide linkages and the L-configured residues supports stable behavior under typical assay conditions and helps maintain consistent conversion to AMC-containing products. The TFA salt form can improve reproducibility in aqueous or buffer-containing analytical workflows by stabilizing the protonation state of the amine. The resulting fluorescence response can be used to generate standard curves and to benchmark analytical sensitivity across batches of peptide-based reagents.

5. Specialty Peptide Intermediate Use

H-L-Met-AMC*TFA can be employed as a specialty amino acid/peptide derivative intermediate in synthetic organic chemistry for preparing related AMC-tagged substrates or sequence analogs. The compound contains a protected/functionalized peptide architecture with an AMC reporter, providing a direct handle for downstream derivatization strategies such as exchanging the terminal leaving group, modifying side-chain functionality, or extending the peptide chain for longer substrate constructs. The methionine thioether side chain offers a chemically informative sulfur-containing motif that can be carried through to generate derivatives for studying oxidation sensitivity, thioether reactivity, or sulfur-specific recognition. The TFA salt form also indicates that amine protonation can be managed during coupling or purification steps in fine chemical synthesis. The compound therefore supports industrially relevant peptide building block preparation where sequence-defined, fluorogenic reagents are manufactured for biochemical instrumentation and screening platforms.

1. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

2. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

3. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

5. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury